These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9021181)

  • 1. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene.
    Stuyver L; Wyseur A; Rombout A; Louwagie J; Scarcez T; Verhofstede C; Rimland D; Schinazi RF; Rossau R
    Antimicrob Agents Chemother; 1997 Feb; 41(2):284-91. PubMed ID: 9021181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay.
    Wilson JW; Bean P; Robins T; Graziano F; Persing DH
    J Clin Microbiol; 2000 Aug; 38(8):3022-8. PubMed ID: 10921971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.
    Servais J; Lambert C; Fontaine E; Plesséria JM; Robert I; Arendt V; Staub T; Schneider F; Hemmer R; Burtonboy G; Schmit JC
    J Clin Microbiol; 2001 Feb; 39(2):454-9. PubMed ID: 11158089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a point mutation assay with a line probe assay for the detection of the major mutations in the HIV-1 reverse transcriptase gene associated with reduced susceptibility to nucleoside analogues.
    Clarke JR; Kaye S; Babiker AG; Hooker MH; Tedder R; Weber JN
    J Virol Methods; 2000 Aug; 88(2):117-24. PubMed ID: 10960699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of line probe assay (LIPA) and sequence analysis for detection of HIV-1 drug resistance.
    Puchhammer-Stöckl E; Schmied B; Mandl CW; Vetter N; Heinz FX
    J Med Virol; 1999 Mar; 57(3):283-9. PubMed ID: 10022801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing.
    Reinis M; Vandasová J; Stanková M; Linka M; Brůcková M
    Acta Virol; 2001; 45(5-6):279-86. PubMed ID: 12083326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation patterns of the reverse transcriptase genes in HIV-1 infected patients receiving combinations of nucleoside and non nucleoside inhibitors.
    Re MC; Bon I; Monari P; Borderi M; Gibellini D; Schiavone P; Vitone F; Chiodo F; La Placa M
    Int J Antimicrob Agents; 2003 Oct; 22(4):388-94. PubMed ID: 14522102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
    Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
    Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89.
    Tisdale M; Alnadaf T; Cousens D
    Antimicrob Agents Chemother; 1997 May; 41(5):1094-8. PubMed ID: 9145875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis.
    Koch N; Yahi N; Colson P; Fantini J; Tamalet C
    J Virol Methods; 1999 Jun; 80(1):25-31. PubMed ID: 10403673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysis.
    Descamps D; Calvez V; Collin G; Cécille A; Apetrei C; Damond F; Katlama C; Matheron S; Huraux JM; Brun-Vézinet F
    J Clin Microbiol; 1998 Jul; 36(7):2143-5. PubMed ID: 9650987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215.
    Rusconi S; La Seta Catamancio S; Sheridan F; Parker D
    J Clin Virol; 2000 Dec; 19(3):135-42. PubMed ID: 11090748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the LiPA HIV-1 RT assay version 1: comparison of sequence and hybridization based genotyping systems.
    Stürmer M; Morgenstern B; Staszewski S; Doerr HW
    J Clin Virol; 2002 Dec; 25 Suppl 3():S65-72. PubMed ID: 12467779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals.
    Brindeiro R; Vanderborght B; Caride E; Correa L; Oravec RM; Berro O; Stuyver L; Tanuri A
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1674-80. PubMed ID: 10390221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection of the HIV type 1 reverse transcriptase codon T215Y by reverse transcription-polymerase chain reaction with fluorogenic probes.
    Ross L; Vavro C; Zimmermann A; St Clair M
    AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1287-92. PubMed ID: 10505677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast genotypic detection of drug resistance mutations in the HIV-1 reverse transcriptase gene of treatment-naive patients.
    Fontaine E; Lambert C; Servais J; Ninove D; Plesséria JM; Staub T; Arendt V; Kirpach P; Robert I; Schneider F; Hemmer R; Schmit JC
    J Hum Virol; 1998; 1(7):451-6. PubMed ID: 10195266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase.
    Hanna GJ; Johnson VA; Kuritzkes DR; Richman DD; Martinez-Picado J; Sutton L; Hazelwood JD; D'Aquila RT
    J Clin Microbiol; 2000 Jul; 38(7):2715-21. PubMed ID: 10878069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences.
    Yahi N; Tamalet C; Tourrès C; Tivoli N; Ariasi F; Volot F; Gastaut JA; Gallais H; Moreau J; Fantini J
    J Clin Microbiol; 1999 Dec; 37(12):4099-106. PubMed ID: 10565938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of viral resistance to reverse transcriptase inhibitors (RTI) in HIV-1-infected patients before and after 6 months of single or double antiretroviral therapy.
    Brites C; Bahia F; Gilbert M; Pedroso C; Badaró R
    Braz J Infect Dis; 2001 Aug; 5(4):177-82. PubMed ID: 11712962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years.
    Winters MA; Shafer RW; Jellinger RA; Mamtora G; Gingeras T; Merigan TC
    Antimicrob Agents Chemother; 1997 Apr; 41(4):757-62. PubMed ID: 9087484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.